IP Library Granted Patent US 12,171,660
Granted Patent B2
US 12,171,660 · App. 17/535,381 · Granted Dec 24, 2024

Transcatheter device for treating tricuspid valve regurgitation

Inventor: June Hong Kim (Busan, KR)
Assignees: TAU MEDICAL USA, INC.; TAU MEDICAL, INC.
A61F2/246A61F2/2466A61M25/0041A61M25/04A61M25/09A61M2025/1097
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,171,660
App. No.
17/535,381
Granted
Dec 24, 2024
Kind
B2
Abstract

A transcatheter device for treating the tricuspid valve regurgitation. The transcatheter device comprises a main shaft, a proximal portion, a distal tail, and a spacer body mounted on the main shaft and located between the proximal portion and the distal tail. This transcatheter device could be used for treating tricuspid valve regurgitation in a patient's heart. All or part of the transcatheter device is supported by the main shaft. The spacer body is mounted on the shaft, which travels through the spacer body. Also disclosed are a coaptation assembly that comprises the transcatheter device, and a method of treating tricuspid valve regurgitation using the transcatheter device.

Claims (32)

1. A method of treating tricuspid valve regurgitation in a patient's heart, comprising:

having a transcatheter device comprising (i)-(iv) below;

(i) a main shaft;

(ii) a proximal portion comprising a proximal segment of the main shaft and an intravascular anchor;

(iii) a distal tail comprising a distal portion of the main shaft;

(iv) a spacer body mounted on the main shaft and located between the proximal segment of the main shaft and the distal tail;

inserting the transcatheter device into a femoral vein;

advancing the transcatheter device through an inferior vena cava;

advancing the transcatheter device through a right atrium of the heart;

advancing the transcatheter device across a tricuspid valve and into a right ventricle of the heart;

advancing the transcatheter device towards a pulmonary artery;

advancing the distal tail into the pulmonary artery for a distance of at least 10 cm into the pulmonary artery;

positioning the spacer body between leaflets of the tricuspid valve;

lodging the intravascular anchor within the inferior vena cava.

2. The method of claim 1 , further comprising positioning the spacer body to abut against a supraventricular crest of the heart.

3. The method of claim 2 , wherein the abutting against the supraventricular crest occurs at a location within the distal half of the spacer body.

4. The method of claim 2 , wherein the tricuspid valve has a tricuspid annulus and there is an annular plane defined for the tricuspid annulus;

wherein the annular plane is along an x-axis of the tricuspid annulus and orthogonal to a Y-axis of the tricuspid annulus;

wherein the spacer body is positioned at an oblique angle relative to the annular plane.

5. The method of claim 2 , wherein the main shaft comprises a lumen, and the method further comprises:

inserting a guidewire into the femoral vein;

advancing the guidewire through the inferior vena cava;

advancing the guidewire through the right atrium;

advancing the guidewire to traverse the tricuspid valve and into the right ventricle;

introducing the guidewire into the lumen of the shaft;

advancing the transcatheter device over the guidewire.

6. The method of claim 1 , wherein the distal tail is advanced past a first branching point of the pulmonary artery.

7. The method of claim 6 , wherein the distal tail is advanced past a second branching point of the pulmonary artery.

8. The method of claim 7 , wherein the distal tail of the transcatheter device is advanced past a third branching point of the pulmonary artery.

9. The method of claim 1 , wherein the distal tail of the transcatheter device is advanced a least 15 cm into the pulmonary artery.

10. The method of claim 1 , wherein the spacer body has an opening through which blood flows through the spacer body.

11. The method of claim 1 , wherein the pulmonary artery is a left-side pulmonary artery.

Assignments (4)
CHANGE OF NAME Recorded Nov 5, 2024
From: TAU CARDIO, INC.
To: TAU MEDICAL USA, INC.
Reel/Frame 069307/0813 →
CORRECTIVE ASSIGNMENT TO CORRECT THE FIRST ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 062203 FRAME: 0145. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jan 12, 2023
From: KIM, JUNE-HONG
To: TAU CARDIO INC.; TAU MEDICAL INC.
Reel/Frame 062380/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2022
From: KIM, JUNE-HONG
To: TAU MEDICAL INC.; TAU MEDICAL INC.,
Reel/Frame 062202/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2022
From: KIM, JUNE-HONG
To: TAU MEDICAL INC.,; TAU MEDICAL INC.
Reel/Frame 062203/0145 →
Continuity (9)
Provisional Application 63283032 · Nov 24, 2021
Provisional Application 63227871 · Jul 30, 2021
Provisional Application 63224337 · Jul 21, 2021
Provisional Application 63180656 · Apr 28, 2021
Provisional Application 63163772 · Mar 19, 2021
Provisional Application 63146552 · Feb 5, 2021
Provisional Application 63137589 · Jan 14, 2021
Provisional Application 63118631 · Nov 25, 2020
Related Publication 20220160500A1 · May 26, 2022